Potential therapeutic options for COVID-19: an update on current evidence.


Journal

European journal of medical research
ISSN: 2047-783X
Titre abrégé: Eur J Med Res
Pays: England
ID NLM: 9517857

Informations de publication

Date de publication:
13 Jan 2022
Historique:
received: 02 10 2021
accepted: 23 12 2021
entrez: 14 1 2022
pubmed: 15 1 2022
medline: 27 1 2022
Statut: epublish

Résumé

SARS-CoV-2, a novel coronavirus, is the agent responsible for the COVID-19 pandemic and is a major public health concern nowadays. The rapid and global spread of this coronavirus leads to an increase in hospitalizations and thousands of deaths in many countries. To date, great efforts have been made worldwide for the efficient management of this crisis, but there is still no effective and specific treatment for COVID-19. The primary therapies to treat the disease are antivirals, anti-inflammatories and respiratory therapy. In addition, antibody therapies currently have been a many active and essential part of SARS-CoV-2 infection treatment. Ongoing trials are proposed different therapeutic options including various drugs, convalescent plasma therapy, monoclonal antibodies, immunoglobulin therapy, and cell therapy. The present study summarized current evidence of these therapeutic approaches to assess their efficacy and safety for COVID-19 treatment. We tried to provide comprehensive information about the available potential therapeutic approaches against COVID-19 to support researchers and physicians in any current and future progress in treating COVID-19 patients.

Identifiants

pubmed: 35027080
doi: 10.1186/s40001-021-00626-3
pii: 10.1186/s40001-021-00626-3
pmc: PMC8755901
doi:

Substances chimiques

Antibodies, Monoclonal 0
Antibodies, Neutralizing 0
Antiviral Agents 0
Immunoglobulins, Intravenous 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

6

Informations de copyright

© 2022. The Author(s).

Références

Int J Mol Med. 2020 Aug;46(2):467-488
pubmed: 32468014
J Allergy Clin Immunol. 2020 Jul;146(1):137-146.e3
pubmed: 32470486
Biol Proced Online. 2020 Jul 23;22:15
pubmed: 32754003
Front Immunol. 2019 Mar 22;10:548
pubmed: 30967872
JAMA. 2020 Dec 8;324(22):2292-2300
pubmed: 33180097
Clin Transl Med. 2021 Feb;11(2):e297
pubmed: 33634996
Lancet. 2021 Sep 4;398(10303):843-855
pubmed: 34388395
Stem Cells Int. 2019 Apr 9;2019:9628536
pubmed: 31093291
Crit Care. 2020 Jun 16;24(1):353
pubmed: 32546188
J Biomed Sci. 2020 Dec 20;27(1):104
pubmed: 33341119
Signal Transduct Target Ther. 2020 Aug 27;5(1):172
pubmed: 32855385
Clin Exp Med. 2021 May;21(2):167-179
pubmed: 33128197
Proc Natl Acad Sci U S A. 2020 Oct 13;117(41):25254-25262
pubmed: 32989130
Syst Rev. 2020 Nov 20;9(1):262
pubmed: 33218366
J Clin Med. 2020 Jul 02;9(7):
pubmed: 32630746
Sci Rep. 2021 May 26;11(1):11022
pubmed: 34040117
Bioimpacts. 2020;10(4):209-215
pubmed: 32983936
Signal Transduct Target Ther. 2021 Feb 10;6(1):58
pubmed: 33568628
Stem Cell Res Ther. 2020 Sep 18;11(1):404
pubmed: 32948252
Stem Cells Transl Med. 2021 May;10(5):660-673
pubmed: 33400390
Mol Med. 2020 Sep 29;26(1):91
pubmed: 32993479
Nutrients. 2021 Apr 12;13(4):
pubmed: 33921297
Hypertens Res. 2021 Aug;44(8):1042-1045
pubmed: 34017093
Head Neck. 2020 Jun;42(6):1252-1258
pubmed: 32342566
Thorax. 2021 Sep;76(9):907-919
pubmed: 33579777
Nat Rev Immunol. 2021 Jun;21(6):382-393
pubmed: 33875867
BMC Infect Dis. 2021 May 27;21(1):489
pubmed: 34044777
Stem Cell Rev Rep. 2019 Apr;15(2):166-175
pubmed: 30623359
J Cell Physiol. 2021 Apr;236(4):2519-2543
pubmed: 33022076
ACS Cent Sci. 2020 Mar 25;6(3):315-331
pubmed: 32226821
Lancet Respir Med. 2021 Jul;9(7):763-772
pubmed: 33844996
Lancet Respir Med. 2021 Sep;9(9):957-968
pubmed: 34147142
Asian Pac J Allergy Immunol. 2020 Mar;38(1):10-18
pubmed: 32134278
BMJ Open. 2021 Jun 24;11(6):e048416
pubmed: 34168031
Nutrients. 2021 Jun 24;13(7):
pubmed: 34202578
Inflamm Res. 2020 Dec;69(12):1181-1189
pubmed: 32918567
Ann Intern Med. 2021 May;174(5):663-672
pubmed: 33560863
EClinicalMedicine. 2021 Jun 18;37:100962
pubmed: 34189447
Stem Cells Dev. 2021 Oct 1;30(19):947-969
pubmed: 34416823
Lancet. 2020 May 16;395(10236):1569-1578
pubmed: 32423584
Contemp Clin Trials. 2021 Feb;101:106272
pubmed: 33422642
Signal Transduct Target Ther. 2021 Feb 21;6(1):83
pubmed: 33612824
Iran J Allergy Asthma Immunol. 2020 May 17;19(S1):3-6
pubmed: 32534509
Stem Cell Res Ther. 2021 Jan 29;12(1):91
pubmed: 33514427
JAMA. 2020 Oct 6;324(13):1330-1341
pubmed: 32876694
J Med Virol. 2020 Nov;92(11):2631-2636
pubmed: 32501538
Ther Adv Chronic Dis. 2021 Aug 20;12:20406223211039699
pubmed: 34434540
Transfus Clin Biol. 2016 Feb;23(1):39-44
pubmed: 26775794
Front Med. 2020 Oct;14(5):664-673
pubmed: 32761491
PLoS Pathog. 2021 Sep 3;17(9):e1009885
pubmed: 34478455
Ann Intensive Care. 2021 Jan 9;11(1):5
pubmed: 33420963
BMC Infect Dis. 2021 Apr 10;21(1):337
pubmed: 33838657
Adv Exp Med Biol. 2018;1119:103-118
pubmed: 30155859
PLoS One. 2021 Mar 16;16(3):e0248009
pubmed: 33724987
N Engl J Med. 2021 Jul 29;385(5):406-415
pubmed: 34133856
Aging Dis. 2020 Mar 9;11(2):216-228
pubmed: 32257537
Leukemia. 2021 Sep;35(9):2616-2620
pubmed: 33990684
EClinicalMedicine. 2021 Jul;37:100981
pubmed: 34222847
Pathogens. 2020 Nov 05;9(11):
pubmed: 33167401
N Engl J Med. 2021 Mar 4;384(9):795-807
pubmed: 33306283
Int Immunopharmacol. 2021 Jul;96:107732
pubmed: 34162133
Front Med (Lausanne). 2015 Feb 04;2:4
pubmed: 25699258
Biomed Pharmacother. 2021 Jun;138:111544
pubmed: 34311539
Cytokine. 2021 Oct;146:155627
pubmed: 34237556
Interdiscip Perspect Infect Dis. 2022 Jan 29;2022:4693121
pubmed: 35103059
N Engl J Med. 2021 Aug 26;385(9):777-789
pubmed: 34351722
Crit Care Res Pract. 2021 Apr 23;2021:8881115
pubmed: 33986957
Gastroenterol Hepatol Bed Bench. 2020 Fall;13(4):374-387
pubmed: 33244381
Crit Care Explor. 2020 Nov 16;2(11):e0280
pubmed: 33225306
Comput Biol Med. 2020 Jun;121:103749
pubmed: 32568687
Mol Psychiatry. 2021 Sep;26(9):5199-5212
pubmed: 33536545
Virus Res. 2020 Sep;286:198070
pubmed: 32569708
Stem Cell Rev Rep. 2021 Feb;17(1):56-62
pubmed: 33009982
Curr Stem Cell Res Ther. 2019;14(1):22-33
pubmed: 30210006
Clin Rheumatol. 2020 Jul;39(7):2085-2094
pubmed: 32474885
Adv Pharm Bull. 2022 Mar;12(2):206-216
pubmed: 35620342
Biomed Pharmacother. 2022 Jan;145:112420
pubmed: 34801852
Stem Cell Rev Rep. 2021 Feb;17(1):193-213
pubmed: 33511518
Indian J Hematol Blood Transfus. 2021 Jul;37(3):347-365
pubmed: 33746378
Microbiol Aust. 2020 Mar 17;:MA20013
pubmed: 32226946
Rheumatology (Oxford). 2021 Dec 1;60(12):5527-5537
pubmed: 33999135
Turk J Med Sci. 2020 Apr 17;50(SI-1):620-632
pubmed: 32299202
Cell Host Microbe. 2018 Aug 8;24(2):221-233.e5
pubmed: 30092199
Signal Transduct Target Ther. 2021 Jul 7;6(1):255
pubmed: 34234112
Autoimmun Rev. 2020 Jul;19(7):102554
pubmed: 32380316
Front Immunol. 2020 Jun 23;11:1512
pubmed: 32655581
medRxiv. 2021 Dec 21;:
pubmed: 34981077
J Infect. 2021 Apr;82(4):e34-e35
pubmed: 33373651
PLoS One. 2021 May 25;16(5):e0252057
pubmed: 34033648
Eur Respir J. 2020 Dec 24;56(6):
pubmed: 32943404
J Autoimmun. 2020 Jul;111:102452
pubmed: 32291137
BMC Infect Dis. 2021 Jan 11;21(1):47
pubmed: 33430799
N Engl J Med. 2021 Sep 23;385(13):1184-1195
pubmed: 34347950
JAMA. 2021 Apr 27;325(16):1620-1630
pubmed: 33734299
Stem Cell Res Ther. 2020 Aug 18;11(1):361
pubmed: 32811531
Eur Respir J. 2021 Jul 8;58(1):
pubmed: 33361100
Ann Med Surg (Lond). 2021 Sep;69:102779
pubmed: 34512959
Postgrad Med J. 2022 Jul 1;98(1161):509-514
pubmed: 37066509
Stem Cell Rev Rep. 2020 Jun;16(3):427-433
pubmed: 32281052
N Engl J Med. 2021 Oct 7;385(15):1382-1392
pubmed: 34260849
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2020 Apr;32(4):417-420
pubmed: 32527344
Clin Transl Immunology. 2020 Oct 16;9(10):e1198
pubmed: 33088506
Lancet Rheumatol. 2021 Oct;3(10):e690-e697
pubmed: 34396156
Mayo Clin Proc. 2021 May;96(5):1262-1275
pubmed: 33958057
Sci Rep. 2021 Jun 21;11(1):12948
pubmed: 34155232
Risk Manag Healthc Policy. 2020 Sep 23;13:1711-1721
pubmed: 33061705
N Engl J Med. 2020 Jun 11;382(24):2327-2336
pubmed: 32275812
Cell. 2020 Apr 16;181(2):271-280.e8
pubmed: 32142651
medRxiv. 2020 Aug 12;:
pubmed: 32817978
Acta Anaesthesiol Scand. 2021 Nov;65(10):1447-1456
pubmed: 34368946
Front Immunol. 2020 Jul 03;11:1625
pubmed: 32719685
Asian Pac J Allergy Immunol. 2020 Mar;38(1):1-9
pubmed: 32105090
Aging Dis. 2020 Mar 9;11(2):462-464
pubmed: 32257554
Naunyn Schmiedebergs Arch Pharmacol. 2021 May;394(5):829-838
pubmed: 33587164
Nutrients. 2021 Jun 03;13(6):
pubmed: 34205138
Nature. 2020 Sep;585(7824):273-276
pubmed: 32516797
Cell Death Differ. 2020 May;27(5):1451-1454
pubmed: 32205856
Front Microbiol. 2020 Aug 13;11:1818
pubmed: 32903349
EClinicalMedicine. 2020 Aug;25:100454
pubmed: 32838232
JAMA. 2021 Jul 6;326(1):46-55
pubmed: 34081073

Auteurs

Zahra Niknam (Z)

Proteomics Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Ameneh Jafari (A)

Advanced Therapy Medicinal Product (ATMP) Department, Breast Cancer Research Center, Motamed Cancer Institute, ACECR, Tehran, Iran.

Ali Golchin (A)

Department of Clinical Biochemistry and Applied Cell Sciences, School of Medicine, Urmia University of Medical Sciences, Urmia, Iran.

Fahima Danesh Pouya (F)

Department of Biochemistry, School of Medicine, Urmia University of Medical Sciences, Urmia, Iran.

Mohadeseh Nemati (M)

Department of Biochemistry, School of Medicine, Urmia University of Medical Sciences, Urmia, Iran.

Mostafa Rezaei-Tavirani (M)

Proteomics Research Center, Faculty of Paramedical Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran. tavirany@yahoo.com.

Yousef Rasmi (Y)

Department of Biochemistry, School of Medicine, Urmia University of Medical Sciences, Urmia, Iran. yrasmi@gmail.com.
Cellular and Molecular Research Center, Urmia University of Medical Sciences, Urmia, Iran. yrasmi@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH